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Abstract. To examine the mechanism through which 
neurofilaments regulate the caliber of myelinated ax- 
ons and to test how aberrant accumulations of neurofil- 
aments cause motor neuron disease, mice have been 
constructed that express wild-type mouse NF-H up to 
4.5 times the normal level. Small increases in NF-H ex- 
pression lead to increased total neurofilament content 
and larger myelinated axons, whereas larger increases 
in NF-H decrease total neurofilament content and 
strongly inhibit radial growth. Increasing NF-H expres- 
sion selectively slows neurofilament transport into and 
along axons, resulting in severe perikaryal accumula- 
tion of neurofilaments and proximal axonal swellings in 
motor neurons. Unlike the situation in transgenic mice 
expressing modest levels of human NF-H (Cote, F., J.F. 
Collard, and J.P. Julien. 1993. Cell. 73:35-46), even 4.5 
times the normal level of wild-type mouse NF-H does 
not result in any overt phenotype or enhanced motor 
neuron degeneration or loss. Rather, motor neurons 
are extraordinarily tolerant of wild-type murine NF-H, 
whereas wild-type human NF-H, which differs from 
the mouse homolog at >160 residue positions, mediates 
motor neuron disease in mice by acting as an aberrant, 
mutant subunit. 
S 
INCE the initial visualization of neurofilaments by sit- 
ver staining in the early nineteenth century, mount- 
mg  evidence  has  pointed  to  their  importance  in 
specifying axonal diameter (caliber) (Friede and Samoraj- 
ski, 1970; Hoffman et al., 1987; Cleveland et al., 1991; Lee 
and  Cleveland, 1994).  The increase  in axonal diameter, 
which initiates concomitantly with myelination and contin- 
ues at a slow rate throughout adulthood, is important for 
normal functioning of the nervous system, since caliber is a 
principal determinant of the conduction velocity at which 
nerve impulses are propagated along the axon (Gasser and 
Grundfest, 1939; Arbuthnott et al., 1980; Sakaguchi et al., 
1993). Assembled as obligate heteropolymers (Ching and 
Liem, 1993; Lee et al., i993) of three polypeptide subunits, 
NF-L (68 kD), NF-M (95 kD), and NF-H (115 kD), neuro- 
filaments are the most abundant cytoskeletal components 
in large myelinated axons. The importance of neurofila- 
ments  in  specifying' normal  axonal  caliber  has  recently 
been proven unequivocally by analysis of a recessive mu- 
tation (quv) in a Japanese quail that lacks neurofilaments 
as the result of a premature translation terminator in the 
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NF-L gene (Ohara et al., 1993). Radial growth fails com- 
pletely in these animals (Yamasaki et al., 1992; Ohara et 
al., 1993), with a consequent reduction in axonal conduc- 
tion velocity and generalized quivering (Sakaguchi et al., 
1993).  Nearly total inhibition of neurofilament transport 
into axons by expression of a NF-H-~-galactosidase fusion 
protein in transgenic mice has also been shown to result in 
similar inhibition of radial growth of large myelinated ax- 
ons (Eyer and PetersOn, 1994). 
Although it is clear that neurofilaments are important 
for specifying axonal diameter, the  mechanism through 
which neurofilaments mediate increase in axonal size re- 
mains unsettled. The linear correlation between neurofila- 
ment number and axonal cross-sectional area initially sug- 
gested that the axon expanded or contracted to maintain a 
constant  density  of  neurofilaments  (Friede  and  Samo- 
rajski, 1970; Hoffman et al., 1987).  However, analysis of 
transgenic mice that express elevated levels of wild-type 
NF-L reveals that despite a two- to threefold increase in 
number of neurofilaments, the  axonal diameter actually 
decreases slightly (Monteiro et al., 1990; Xu et al., 1993). 
Thus, while neurofilaments are required for normal radial 
growth of myelinated axons, determination of axonal di- 
ameter is specified by other factors in addition to simple 
neurofilament number. Since the long, highly phosphory- 
lated tail domains of NF-H and, to a lesser extent, NF-M 
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ing in  axons  (de  Waegh  et al.,  1992;  Hsieh et al.,  1994; 
Nixon et al., 1994), one reasonable postulate is that in mice 
expressing high levels of NF-L, dilution of these tail do- 
mains results in inhibition of proper radial growth. 
Correlative evidence suggests that NF-H has a  special 
modulatory role in neurofilament-dependent radial growth 
of axons. Although the expression level of NF-L and NF-M 
mRNA increases more modestly, the increase in the level 
of NF-H mRNA is most pronounced during the rapid ra- 
dial  growth  phase  (0-4  wk  postnatal)  (Schlaepfer  and 
Bruce, 1990). Indirect evidence for an essential role of 
NF-H in radial growth has emerged from doubling NF-M 
content  through  expression of an  epitope-tagged NF-M 
transgene.  This yields a  50%  reduction  in  axonal NF-H 
and strongly inhibits radial growth, despite a constant level 
of NF-L (Wong et al.,  1995).  Furthermore, it is now well 
established  that  the  tail  domains  of  NF-M  and  NF-H 
project from the "core" filament both in vitro (Hirokawa 
et al.,  1984; Troncoso et al.,  1990)  and in mature  axons 
(Hirokawa et al., 1984).  Phosphorylation of these tail do- 
mains is strongly correlated with radial growth. For exam- 
ple, in the Trembler  mouse a primary defect in myelination 
decreases phosphorylation of NF-H, increases neurofila- 
ment density, and inhibits normal radial growth of axons 
(de  Waegh  et  al.,  1992).  Similarly,  unmyelinated initial 
segments  have  dephosphorylated NF-H,  higher  filament 
packing density (Hsieh et al., 1994; Nixon et al., 1994), and 
much smaller diameters than the adjacent myelinated seg- 
ments. Moreover, slowing of slow axonal transport during 
early postnatal development correlates with the increases 
in NF-H expression, prompting the suggestion that NF-H 
modulates the rate of slow axonal transport (Willard and 
Simon, 1983). 
In addition to the normal role of neurofilaments in ra- 
dial growth of myelinated axons, the observations that ab- 
normal accumulations of neurofilaments are an early com- 
mon pathological hallmark in patients with motor neuron 
disease (Carpenter, 1968; Chou and Fakadej, 1971; Hirano 
et al., 1984a, b; for review see Hirano, 1991) have led to the 
hypothesis that abnormalities in neurofilament organiza- 
tion may be involved in the pathogenesis of human motor 
neuron  disease,  including  amyotrophic  lateral  sclerosis 
(ALS).  1 Furthermore, it is now clear that neurofilament 
abnormalities  can  cause  motor neuron  disease  in  some 
transgenic mouse models. Specifically, high levels of wild- 
type neurofilament subunit expression, either murine NF-L 
(Xu et al.,  1993)  or human NF-H (Cote et al.,  1993), in 
transgenic mice lead to perikaryal and axonal accumula- 
tion of neurofilaments accompanied by motor neuron dys- 
function and neurogenic atrophy of skeletal muscle. Fur- 
thermore, expression of a modest level of a mutant NF-L 
subunit leads to both cytoskeletal abnormalities and selec- 
tive death of large spinal motor neurons (Lee et al., 1994). 
We have now directly tested the role of NF-H in neu- 
rofilament-dependent radial  growth  of large  myelinated 
axons by producing a series of transgenic mice that synthe- 
size NF-H at varying levels. Increasing wild-type murine 
NF-H content in neurons selectively retards neurofilament 
1.  Abbreviations used in  this paper:  ALS, amyotrophic lateral  sclerosis; 
DRG, dorsal root ganglia. 
transport while it accelerates transport of other cytoskele- 
tal proteins. Modest increases in NF-H mildly enhance ra- 
dial growth, but higher levels severely retard growth. Even 
4.5 times as much murine NF-H does not result in overt 
phenotype or motor neuron dysfunction despite perikarya 
extraordinarily distended with aggregated neurofilaments 
and inhibition of radial growth. Since this contrasts with 
progressive  neuronopathy  reported  in  mice  expressing 
lower levels of human NF-H (Cote et al., 1993; Collard et al., 
1995), human NF-H must cause disease in mice by acting 
as a mutant subunit. 
Materials And Methods 
Production and Screening of Transgenic Mice 
The 23-kb SalI fragment from a mouse NF-H cosmid (Cos 3A1; Julien et al., 
1988) containing the entire mouse NF-H coding region and the 15 kb of 5' 
flanking region (see Fig. 1 A) were purified by electroelution after agarose 
gel electrophoresis. The DNA was microinjected into pronuclei of one- 
cell mouse embryos obtained by mating C57B6  ×  C3 F1  females with 
C57B6 males. Mouse pups were analyzed for the presence of the NF-H 
transgene by DNA blotting of mouse tail DNA as described (Monteiro et al., 
1990; Xu et al., 1993).  Tail DNAs were digested with EcoRV, separated 
on 0.8%  agarose gels, and transferred to GeneScreen Plus membranes 
(New England Biotabs, Beverly, MA). The membrane was incubated with 
1 ×  106 cpm/ml of probe prepared  by random primer extension using 
[et-3ep]dATP and a  1.4-kb EcoRV/AatII fragment from NF-H gene con- 
taining the sequences encoding some of the KSP multiphosphorylation re- 
peats and part of the NF-H 3' flanking region. A 5-kb transgene-specific 
fragment was  diagnostic for  transgenic animals with  greater than one 
transgene copy integrated in tandem. 
Analysis of  Neurofilament RNA Levels in 
Nervous Tissues 
Spinal cords and dorsal root ganglia were removed from NF-H transgenic 
and wild-type mice and immediately frozen and stored at  -80°C. Total 
cellular RNA was purified using TRIzol reagent (GIBCO BRL, Gaithers- 
burg, MD) and the method provided by manufacturer. RNA for 1-yr-old 
animals was extracted by homogenization of tissue in 4  M  guanidinium 
thiocyanate, 25 ~M sodium citrate, pH 7, 0.1 M  2-metcaptoethanol, and 
0.5%  Sarkosyl.  An equal volume of acidic phenol was added,  and the 
aqueous phase was collected after centrifugation. RNA was then precipi- 
tated with an equal volume of isopropanol and collected by centrifuga- 
tion. RNA was further purified by resuspension in 4 M  lithium chloride 
and subsequent centrifugation. The RNA was again suspended, and then 
precipitated with an equal volume of isopropanol. The pellet was rinsed 
with 75% ethanol and resuspended in 0.3% SDS. RNA concentration was 
determined by determining the absorbance at 260 nm. 
2.5 ~g (4-wk-old animals) or 2 }xg (1-yr-old animals) of total RNA was 
fractionated on a  1%  agarose gel containing 1.85%  formaldehyde and, 
transferred to GeneScreen Plus II. The filters were baked for 2 h at 80°C, 
prehybridized for 1 h in 0.5 M sodium phosphate, pH 7.2,  1 mM EDTA, 
7% SDS, and 1% bovine albumin, and RNAs encoding neurofilament sub- 
units were detected by hybridization with random primed [a-32P]dATP la- 
beled nucleotide probe. Filters were then washed in 30 mM Tris, pH 7.4, 
and 300  mM NaCl,  for 20 min at  room temperature,  followed by two 
washes (30 rain each at 60°C) in 3 mM Tris, pH 7.4,  30 mM NaCl, and 
0.5% SDS. RNA bands corresponding to different neurofilament subunits 
were  visualized by  autoradiography using x-ray film (XAR;  Eastman- 
Kodak Co., Rochester, NY) and quantified by phosphorimaging (Molecu- 
lar Dynamics, Sunnyvale, CA). 
SDS-PAGE and Detection of  Neurofilament Proteins 
by Immunoblotting 
Sciatic nerves and spinal cords were homogenized (with a  polytron ho- 
mogenizer) in a buffer containing 25 mM sodium phosphate, pH 7.2, 5 mM 
EDTA, pH 8, and 1% SDS. The homogenates were boiled for 5 rain and 
clarified by centrifugation at 16,000 g  for 5 min, and supernatants were 
transferred to new tubes. Protein concentration was determined using the 
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Protein extracts, as well as known amounts of neurofilament standards, 
were separated by SDS-PAGE using gels containing 6 or 7.5% polyacryl- 
amide. Proteins separated by SDS-PAGE were transferred to nitrocellu- 
lose (Lopata and Cleveland, 1987). The NF-H subunit was identified using 
an affinity-purified rabbit polyclonal antibody (Xu et al., 1993),  followed 
by 125I-conjugated protein A. mAbs to moderately phosphorylated NF-H 
(RMO217  [Lee et al.,  1987]),  NF-M (Boehringer Mannheim Biochemi- 
cals,  Indianapolis, IN),  or NF-L  (Sigma Chemical Co.,  St.  Louis, MO) 
were  used to  identify each subunit, followed by rabbit  anti-mouse IgG 
(Sigma Chemical Co.) and 12SI-conjugated  protein A. The neuron-specific 
13ul-tubulin  isotype was visualized using mAb TuJ1 (Lee et al., 1990)  and 
processed in the same manner as the other mAbs. Immunoreactive bands 
were visualized by autoradiography using Kodak XAR film. Quantifica- 
tion  was  performed  by  phosphorimaging (Molecular  Dynamics)  using 
known amounts of purified  mouse spinal cord  neurofilaments as stan- 
dards. 
Tissue Preparation and Morphological Analysis 
Transgenic and littermate control animals were anesthetized by intraperi- 
toneal injection of (0.02 mug) Avertin, and one or both sciatic nerves, as 
well as a 0.5-cm segment of tail, were removed for biochemical analyses. 
Mouse tissues were  then fixed by intracardial perfusion with 4%  para- 
formaldehyde and 2.5% glutaraldehyde in 0.1 M sodium phosphate, pH 7.6. 
The paraformaldehyde/glutaraldehyde-fixed tissues were postfixed in the 
same fixative for 24 h  at 4°C followed by 2% osmium tetroxide in 0.1 M 
phosphate  buffer,  dehydrated  in  alcohols,  and  embedded  in  Epon- 
Araldite resin. For light microscopy, 1-~m sections were stained with tolu- 
idine blue.  Thin-sections for EM  were  stained with  uranyl acetate  and 
lead citrate. 
Morphometric Analysis 
To determine the diameters of myelinated axons, L5 ventral roots were 
embedded in Epon,  1-v.m sections were  cut and stained with toluidine 
blue, and sections were  viewed under  x100 magnification. The images 
were digitized and converted to a  512 x  512 pixel video display using a 
video camera and frame-grabber video board. All myelinated axons were 
identified, and areas were determined by a morphometric software pro- 
gram (Bioquant MegX; R  & M  Biometrics, Inc., NashviUe, TN). The en- 
tire nerve was measured using contiguous nonoverlapping fields with cen- 
ter-of-gravity exclusion to avoid double counting or size bias in the counts. 
Light level and optimal threshold on a 256 grey-scale were determined for 
each field independently. Cross-sectional area of each axon was measured 
and converted to a diameter of a circle of equivalent area. 
Analysis of Filament Spacing: Nearest 
Neighbor Analysis 
To  measure nearest neighbor distances between  neurofilaments, cross- 
sections of axons >3.0 p~m in diameter were photographed at a magnifica- 
tion of 20,000 and enlarged an additional 4.25-fold by printing. Neurofila- 
ments were identified in these end on views as dots of ~10 nm in diameter. 
Positions of neurofilaments were marked by puncturing the print with a 
pushpin. By laying the final prints on a light box, neurofilament positions 
could easily be imaged using a  CCD camera and digitized using image 
analysis software (Bioquant; R  & M Biometrics, Inc.), and nearest neigh- 
bor distances were calculated for each filament. 
Axonal Transport Analysis 
The velocity of axonally transported neurofilaments was determined in 
8-wk-old transgenic and nontransgenic littermates. To metabolically label 
newly synthesized neurofilaments in motor  axons, 300  ~Ci  of [3SS]me- 
thionine was injected into the ventral horn of the lumbar spinal cord. For 
sensory axons, 100 ~Ci of [3SS]methionine was injected into the L5 dorsal 
root ganglia (DRG).  7 or 14 d  after the injection, the L5 roots or DRG 
and ~3 cm of sciatic nerve were removed and cut into 3-mm segments. 
Each segment was homogenized in a  buffer containing (25 mM sodium 
phosphate, pH 7.0, 150 mM NaC1, 1 mM EDTA, 0.9 M sucrose, 1% Triton 
X-100, and 2 mM PMSF) and centrifuged at 12,000 g for 20 min. Essen- 
tially all of the neurofilament proteins (NF-L, NF-M, and NF-H), along 
with cold insoluble tubulin and actin, were recovered in the pellet fraction. 
The entire pellet (resolubilized in 2% SDS-containing gel sample buffer) 
and the soluble proteins were separated by SDS-PAGE. The distribution 
of [35S]methionine-labeled proteins was visualized by fluorography. The 
radioactivity associated with each of the neurofilament subunits was de- 
termined by phosphorimaging. 
Results 
Transgene Copy Number-dependent  Increase in NF-H 
RNA Levels in NF-H Transgenic Mice 
To examine the consequence of overexpressing wild-type 
murine NF-H, pronuclear microinjection of a 23-kb frag- 
ment containing the complete mouse NF-H gene (Fig. 1 A) 
was  used to produce transgenic  mice.  14  founders were 
identified using DNA blotting of mouse tail DNA (Fig. 1 B), 
10 of which produced progeny that carried the transgene. 
Transgene copy number was determined by phosphorim- 
aging  analysis  of  duplicate  blots  probed  for  the  NF-H 
transgene  or  the  endogenous  NF-L  gene,  the  latter  of 
which was used to normalize for DNA loading (Fig. 1 B). 
Five lines of mice that carry between three and 35 addi- 
tional copies of the NF-H gene were selected for further 
analysis (NF-Hcos 35, 61, 62, 65, and 75). 
To determine the level of NF-H mRNA accumulation 
in  each transgenic  line, RNA was  prepared from spinal 
cord, DRG, and cortex of 4-wk-old animals.  RNA blot 
analysis of spinal cord RNA showed an NF-H gene dosage- 
Figure 1.  Lines  of mice  containing a  transgene  encoding  wild- 
type  murine NF-H.  (A)  Schematic drawing of a  23-kb  SalI/SalI 
NF-Hcos transgene. Lower portion displays a  blowup of the NF-H 
coding region. S, Sail; RV, EcoRV; K, KpnI; N, NotI; X, XhoI; A, 
AatlI. (B) Detection of multiple transgene inserts in six lines de- 
termined by blotting genomic DNAs  after digestion with EcoRV 
and probing with the 1.4-kb EcoRV/AatlI  fragment extending 3' 
from the EcoRV  site in exon 4. Head to tail copies of the trans- 
gene are predicted to yield a 5-kb transgene fragment; the endog- 
enous NF-H fragment is >23 kb. (Bottom) To provide an internal 
control for DNA  loading, the blot was reprobed to reveal the 3-kb 
endogenous NF-L gene fragment. 
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of neurofilament  subunits  in  9-wk-old transgenic  sciatic 
nerve extracts were analyzed by quantitative immunoblot- 
ting (Fig. 3 A). This revealed that in the transgenic mice 
with the smallest increases in NF-H RNA level (lines 65 
and 62), modest (~70%) increases in NF-H subunit levels 
were accompanied by increases in both NF-L and NF-M 
levels, yielding ,-~25% increase in the total molar NF sub- 
unit content (Fig.  3, A  and B). Despite three- to 4.5-fold 
higher levels of NF-H RNA levels in transgenic lines 35, 
Figure 2.  Increased  NF-H mRNA levels in multiple transgenic 
lines. (A) RNA blots of N2.5 I~g of total RNA extracted from spi- 
nal cord of 4-wk-old mice from different transgenic lines probed 
for NF-L, NF-M, and NF-H RNAs. Bottom row displays the 18S 
rRNA region  of an  ethidium  stained  gel to verify equivalent 
RNA loadings. (B) Quantitation of the relative levels of NF-H and 
NF-L RNAs in the five transgenic lines. (C) RNA blots (probed 
for NF-H, NF-M, and NF-L) of spinal cord RNA from 1-yr-old 
transgenic line 75 or normal mice. 
dependent increase in the amount of NF-H message in the 
different transgenic lines (Fig. 2 A), relative to NF-L mRNAs 
(Fig. 2, A and B) or 18S rRNA (Fig. 2 A). Similar increases 
in NF-H RNA levels were observed in both DRG and in 
cortex  of  NF-H  transgenic  mice.  Phosphorimaging  re- 
vealed between 1.2- and 4.5-fold increases in NF-H RNA 
levels relative to NF-L mRNA in the five NF-H transgenic 
lines  (Fig.  2  B),  and  these  levels  remained  elevated 
throughout life (e.g., with greater than four times the nor- 
mal level in 2-yr-old heterozygotes of line 75 [Fig. 2 C], the 
highest  expressing  line).  An  unexpected  finding  (con- 
firmed by phosphorimaging) was that increasing NF-H ex- 
pression led to a diminution (up to twofold in 2-yr-old ani- 
mals from line 75) of endogenous NF-M mRNAs (Fig. 2 A). 
Within  nervous  tissue,  NF-H  immunoreactivity  is  re- 
stricted  to neurons  (not shown), as it is in the wild-type 
mice. Collectively, these results show that the 23-kb NF-H 
transgene drives copy number--dependent increases in NF-H 
expression that reproduce the tissue and cellular specific- 
ity of endogenous NF-H gene expression. 
Increase in NF-H Expression Leads to Reduction in 
Sciatic Nerve Neurofilament Content and Perikaryal 
Neurofilament Accumulations 
To determine if the higher NF-H mRNA levels lead to in- 
Figure 3.  Immunoblotting and quantitation of neurofilament sub- 
units in sciatic nerve of the various NF-H transgenic lines. (A) 
Immunoblot of 5 txg of total  sciatic nerve protein extract  from 
9-wk-old animals. The three subunits were identified with a poly- 
clonal antibody  to NF-H (Xu et al., 1993), or mAbs to NF-M 
(Boehringer Mannheim Biochemicals) or NF-L (Sigma Chemical 
Co.). (B) Relative levels of each neurofilament subunit (in pmol 
per 10 p,g of protein)  determined  by phosphorimaging of sciatic 
nerve immunoblots of 9-wk-old transgenic and wild-type animals 
(measurements are averages from three animals for each group). 
(C)  Immunoblot  of sciatic nerve extracts from 4-wk-old trans- 
genic  animals with an  antibody  (RMO217-p++)  recognizing 
phosphorylated epitopes on NF-H (Lee et al., 1987). 
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sciatic nerve were increased only by 50-70% (denoted by 
the unfilled portions in Fig. 3 B) over the nontransgenic 
control. Furthermore, there were clear decreases in molar 
levels of both NF-L (20--40%) and NF-M (40-60%) pro- 
teins in the sciatic nerve (Fig. 3 B). Even with the modest 
increase in NF-H protein level in the sciatic nerves of line 
75 with the highest NF-H RNA levels, the total molar NF 
content in the sciatic nerve decreased by ,-.~30% at 9 wk 
(Fig. 3 B). Although the accumulated NF-H protein levels 
do not directly correlate with the NF-H mRNA levels, com- 
parison of the molar percentage of NF-H in the sciatic nerve 
does increase as NF-H mRNA levels increase (Figs. 2 B 
and 3, A and B). Examination of protein levels in 4-wk-old 
mice yielded similar results (not shown). The amount of par- 
tially or fully phosphorylated NF-H (using mAb RMO 217; 
Lee et al., 1987)  in the axons of all the transgenic mouse 
lines  increased  roughly in proportion to the  increase in 
NF-H (Fig. 3 D). This indicates that the additional NF-H 
in the axons is phosphorylated to approximately the same 
extent as in wild-type mice. Thus, reduction of axonal cali- 
ber cannot be accounted for by a decreased phosphoryla- 
tion of axonal NF-H. Metabolic labeling of isolated DRG 
and spinal cord did not show any obvious differences in 
the synthesis of NF-L subunits comparing any of the trans- 
genic lines and wild-type mice. The discrepancy between 
the levels of RNA (Fig. 2 A) and axonal polypeptide levels 
(Fig.  3)  must  be  due  to  differences in  posttranslational 
processing of NF subunits. 
To determine if an increase in NF-H expression also af- 
fects the accumulated levels of other axonal cytoskeletal 
components, the level of the neuron-specific 13ni-tubulin 
isotype (Lee et al., 1990) was examined in sciatic nerves. 
Quantitative  immunoblot  analyses  using  the  TuJ1  anti- 
13ui-tubulin  antibody  (Lee et  al.,  1990)  showed  that  in- 
crease in NF-H expression did not have significant effects 
on the axonal level of neuron-specific 13iu-tubulin (Fig. 3 A). 
Light and electron microscopy was used to determine if 
changes  in  wild-type  murine  NF-H  expression  altered 
morphology of spinal and sensory neurons (as has been re- 
ported for transgenic mice expressing human NF-H to a 
level two to threefold above the mouse NF-H [Cote et al., 
1993]). NF-H transgenic line 65, which has the smallest in- 
crease in NF-H RNA (Fig. 2), contained motor (Fig. 4 B) 
and sensory neurons (Fig. 4 F) indistinguishable from the 
neurons in normal mice (Fig. 4, A  and E). However, fur- 
ther increases in the expression of NF-H (in lines 61 and 
75) led to increasingly more severe axonal and perikaryal 
swellings in both spinal cord (Fig. 4, C and D) and DRG 
neurons (Fig. 4, G  and H). The lightly stained hyaline in- 
clusions in these swellings were confirmed to be bundles of 
NFs by transmission EM (data not shown). These results 
indicate that the increase in NF-H synthesis leads to NF-H 
dosage-dependent increases in perikaryal accumulation of 
neurofilaments and a diminution of axonal neurofilament 
content. 
Changes in Sciatic Nerve Neurofilament 
Content Correlate with Changes in Caliber of Large 
Myelinated Axons 
Since neurofilaments are  a  principal  determinant  of ax- 
onal caliber, we examined how the changes in neurofila- 
ment content in sciatic nerve were reflected in changes in 
axonal  caliber  of large  myelinated  axons.  Light  micro- 
scopic inspection of the L5 ventral (Fig. 5, A-D) and dor- 
sal roots (Fig, 5, E-H) revealed that the large myelinated 
axons from NF-H transgenic lines expressing the highest 
levels of NF-H RNA were qualitatively smaller in caliber 
than those of wild-type mice (compare Fig. 5, D-H with A 
and E). 
To  quantify  the  caliber  changes  associated  with  in- 
creased NF-H expression, cross-sectional areas  of every 
axon within each ventral root were measured in 4-wk, 9-wk, 
and  1-yr-old animals  (Fig. 6, A-C). Each area was then 
converted to a diameter corresponding to a circle of equiv- 
alent area. As expected, nontransgenic animals showed a 
bimodal distribution of diameters representing the small 
(neurofilament-deficient) and  large  (neurofilament-rich) 
myelinated axons. In the three NF-H transgenic lines ex- 
pressing the highest levels of NF-H RNA (lines 35, 65, and 
75; data not shown for line 35), the increases in NF-H 
expression lead to a significant inhibition of radial growth of 
large myelinated axons at all ages (Fig. 6), consistent with the 
overall decrease in the axonal NF content in these mice. In 
the older animals, the small diameter axons (<2.5 ~xm) re- 
main unchanged in number or size distribution. However, 
in line 65, which has the smallest increase in NF-H expres- 
sion (Fig. 2), there was a modest but reproducible stimula- 
tion of radial growth of myelinated axons (Fig. 6). 
Overall, these  results  show that  a  modest  increase  in 
NF-H (less than twofold) leads to increased accumulations 
of neurofilaments in  axons  accompanied  by slightly in- 
creased radial growth of large myelinated axons. Larger 
increases  in  NF-H  (greater  than  threefold)  result  in 
perikaryal and proximal axonal accumulations of neurofil- 
aments (Fig. 4, C, D, G, and H) accompanied by a signifi- 
cant inhibition of radial growth (Figs. 4, C, D, G, and H 
and 5, C, D, G, and H). 
Nearest Neighbor Spacing between Neurofilaments 
Is Unaffected by Increase in Axonal NF-H and the 
Concomitant Reduction in NF-M 
To examine whether an increased proportion of NF-H and 
the corresponding reduction in axonal NF-M affects near- 
est neighbor spacing between neurofilaments, the distribu- 
tion  of filaments  in  cross-sections  of ventral  roots  was 
compared from the  highest  expressing NF-H  transgenic 
line (NFHcos 75) and from nontransgenic control animals. 
This revealed that the nearest neighbor packing of fila- 
ments was indistinguishable in transgenic and control ani- 
mals (Fig. 7). 
Increase in NF-H Expression Slows Axonal 
Neurofilament Transport 
Reduction  in  axonal  transport  rates  of  neurofilaments 
with the increase in NF-H expression during development 
(Willard and Simon, 1983) supports a role of NF-H in modu- 
lating the rate of neurofilament transport. Such slowing of 
neurofilament transport has been proposed as a possible 
mechanism  by which  increases  in  axonal  neurofilament 
content and accompanying radial axonal growth occur af- 
ter myelination (Hoffman et al., 1983, 1984). 
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rate of neurofilament transport into and along the axon in 
a  dosage-dependent  manner,  axonal  transport  rates  of 
neurofilaments were initially examined in motor neurons 
of nontransgenic  mice  and  mice  expressing  the  highest 
level of NF-H (line NF-Hcos 75). The distribution of radio- 
labeled polypeptides in both the soluble and cytoskeletal 
phases in the ventral root and the sciatic nerve, represent- 
ing the transport of newly synthesized neurofilament sub- 
units into and along the motor axons, was determined at 
14 d after the injection of [35S]methionine into the ventral 
horn of the spinal cord (Fig. 8). In the transgenic mice ex- 
pressing increased levels of NF-H, transported NF-H and 
NF-L were primarily in the insoluble fraction, as was also 
the case for nontransgenic animals, but the rate of trans- 
port was markedly retarded. In the normal mouse, a peak 
of radioactivity for NF-L, NF-M, and NF-H was found at 
segment 2, a distance ~8 mm from the cell bodies, corre- 
sponding  to a  transport rate  of 0.6  mm/d.  In  the  NF-H 
transgenic  mice, neurofilament transport  was  decreased 
both in amount and in speed (by 2 wk after injection, the 
peak had not yet entered the segments available for analy- 
sis, indicating a slowing by at least two- to threefold). This 
was  a  selective retardation of neurofilament subunits, as 
transport of other components in the insoluble phase was 
unaltered.  Moreover,  increased  synthesis  of  NF-H  re- 
suited  in  a  selective  (approximately twofold)  reduction 
(compared  with  NF-L)  in  the  amount  of NF-M  trans- 
ported (e.g., see cytoskeletal phases of Fig. 8, A  and B), 
consistent with the lower axonal content of NF-M (Fig. 3 B) 
and the lower level of NF-M mRNA  in the spinal cords 
(Fig. 2 A). Inspection of the soluble phase revealed that 
the amount other cargoes moved in slow axonal transport, 
such  as  tubulin  and  actin  (and  an  unidentified  protein 
marked  with  an  asterisk  in  Fig.  8),  was  undiminished, 
while the velocity was  modestly elevated (especially ap- 
parent for tubulin, Fig. 8 B, right). Thus, in motor axons, 
increased synthesis of NF-H leads to selective reduction in 
the  amount  and rate  of transport  of neurofilament sub- 
units, while transport of other components of slow trans- 
port are accelerated in transit rate. 
Axonal transport rates of neurofilaments were also ex- 
amined in sensory axons from normal mice or from mice 
expressing  a  modest  increase  in  NF-H  synthesis  (line 
NF-Hcos 65) and high levels of NF-H synthesis (line NF- 
Hcos 61). Transport of neurofilament subunit-associated 
radioactivity in each of the 3-mm segments was quantified 
by phosphorimaging.  To standardize  comparison among 
multiple animals, the signals were converted to percentage 
of total radioactivity and are displayed in Fig. 9, D-I.  In 
the  nontransgenic  mice,  the  peak  of newly  synthesized 
neurofilaments moved along the axon at ~1-1.2 mm/d, a 
value in  agreement with the expected rate  of neurofila- 
ment  transport  in  sensory  axons  (Hoffman and  Lasek, 
1975;  Hoffman et  al.,  1983).  In line NF-Hcos65, the  in- 
crease in NF-H content slowed neurofilament transport 
slightly (to ~0.8-0.9 mm/d). A  larger increase (,-~3.5-fold) 
in NF-H expression (NF-Hcos 61) retarded neurofilament 
transport to <50% of the nontransgenic rate. In addition, 
an increased level of NF-H also correlated with a selective 
loss of NF-M subunits in the axonally transported subunits 
(compare Fig. 9, A and 9 C), in agreement with the reduc- 
tion in accumulated axonal NF-M (Fig. 3 B). 
Increase in Mouse NF-H Expression Does Not Result 
in Disease or Motor Neuron Degeneration or Death 
In  transgenic  mice  expressing  wild-type  human  NF-H 
mRNA  at  twofold  over  the  endogenous  murine  NF-H 
mRNA  levels,  perikaryal  and  axonal  accumulations  of 
neurofilaments in  neurons, slowing  of axonal neurofila- 
ment transport, and reduction in caliber of large myeli- 
nated motor axons have been reported to be accompanied 
by development of overt clinical abnormalities beginning 
at  as  early as  3-4 mo  of age  and characterized by fine 
tremors, fore-limb weakness, and neurogenic muscle atro- 
phy (Cote et al.,  1993; Collard et al., 1995). Although the 
extent of increase in NF-H expression, the cytoskeletal ab- 
normalities, and decrease in axonal neurofilament trans- 
port  observed in  the  murine  NF-H transgenic  mice  are 
similar to that of the human NF-H transgenic mice, none 
of the five murine NF-H transgenic lines develop an obvi- 
ous phenotype, even at >2 yr of age. Rather, kinetic activ- 
ity, weight gain, muscle mass,  and life span are indistin- 
guishable from nontransgenic littermates. 
To determine if there are presymptomatic changes that 
are consistent with development of motor neuron disease, 
the three highest expressing lines (35, 61, and 75) were ex- 
amined at up to 2 yr of age for any significant loss of motor 
neurons and for development of muscle atrophy. In con- 
trast to the human NF-H transgenic mice, detailed micro- 
scopic examination of sections from multiple skeletal mus- 
cles failed to show any signs of neurogenic atrophy of the 
muscle fibers in any of the lines of murine NF-H trans- 
genie mice. Even very aged (2-yr-old) animals of the high- 
est expressing line (line 75) revealed no statistically signifi- 
cant loss in motor neurons (as determined by counting the 
number of surviving axons in the L4 and L5 ventral roots; 
Fig.  10  C)  and  no  muscle  atrophy  (Fig.  10 A),  despite 
chronically decreased axonal caliber and continuous peri- 
karyal accumulations in motor neurons (Fig. 10 A) that re- 
sulted  in much more grossly distended  cell bodies  than 
those seen in mice developing disease from increased ex- 
pression of murine NF-L (Xu et al., 1993) or human NF-H 
(Cote et al., 1993). Prominent proximal swellings in motor 
neuron axons were seen at all ages. For example, Fig. 10 B 
displays an axonal spheroid (arrow) appearing in the prox- 
imal-most myelinated portion of an axon emerging from a 
motor neuron cell body containing masses of lightly stained 
neurofilaments from a 2-yr-old NF-H line 75 mouse. How- 
ever, these swellings were less frequent than in the NF-L 
(Xu et al., 1993) transgenic animals, and in the NF-H mice, 
not only was there an absence of neuronal loss, but other 
markers  frequently found  in  neurodegenerative disease 
Figure 4.  Neurofilamentous  accumulation in cell bodies of ventral horn motor neurons in NF-H transgenic mice. Light micrographs of 
1-1xm plastic sections (stained with toluidine blue) of (A-D) ventral horn motor neurons at the lumbar bulge and (E-H) L5 dorsal root 
ganglion cell bodies in wild-type and transgenic lines NF-Hcos-65, NF-Hcos-61, and NF-Hcos-75. Bars, 100 I~m. 
Marszalek et al. NF-H  Modulates  Neurofilament Transport  717 Figure 5.  Calibers of motor (ventral root) and sensory (dorsal root) neurons in NF-H transgenic mice. (A-D) Ventral root axons. (E-H) 
Dorsal root axons. Bar, 20 i~m. 
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Figure  7.  Distribution  of nearest  neighbor  distances  between 
neurofilaments in ventral root axons from (O) NF-Hcos 75 trans- 
genic mice or ([3) nontransgenic  littermate control mice. 
a  rate-determining  factor  in  slow  axonal  transport.  The 
present analysis of transgenic mice that express wild-type 
murine NF-H to varying levels demonstrates that changes 
in NF-H synthesis and accumulation can mediate both of 
these events. By varying NF-H levels, two seemingly dif- 
ferent effects occur: mild enhancement of radial growth of 
large myelinated axons by modest increases in NF-H (and 
total NF subunit)  levels (Figs. 3 and 5), but inhibition  of 
radial  growth  concomitant  with  greater  overexpression 
and decrease in axonal neurofilaments. It seems likely that 
were also absent. For example, there was no reactive as- 
trocytosis, as judged by immunocytochemistry with  anti- 
bodies to glial fibrillary acid protein (data not shown). Nor 
did there appear to be loss of mitochondria in axons from 
the  NF-H  mice;  instead,  morphologically  normal  mito- 
chondria were found in the transgenic axons at the same 
frequency per axonal cross-sectional area as the present in 
wild-type axons (e.g., see Fig. 10 A). 
Like the situation in lower motor and sensory neurons, 
an initial survey of the brains of line 75 mice revealed that 
the increased synthesis of NF-H led to neurofilamentous 
swellings in the perikarya and proximal axons in many neu- 
rons, most prominently in the brain stem. Many of these 
also  displayed signs of vacuolar degeneration,  and  there 
was  extracellular  mineral deposition  in  affected regions, 
indicating that the increased burden of NF-H does cause 
subclinical affects in some central nervous system neurons. 
The remainder of the cortical, subcortical, and cerebellar 
neuronal populations appeared normal. 
Discussion 
Earlier indirect evidence implicated a primary role for NF-H 
in determination and maintenance of axonal caliber and as 
Figure 8.  Increasing NF-H levels causes selective slowing of neu- 
rofilament transport in motor axons.  Transport of radiolabeled 
proteins in motor axons of the sciatic nerve from a  (A) 8-wk-old 
nontransgenic mouse and (B) an age-matched NF-Hcos 75 mouse. 
Fluorographs  representing successive  3-mm  segments  from  the 
sciatic nerve are shown both for cytoskeletal (insoluble) fxactions as 
well as for the soluble component of transport. The asterisk marks 
the  mobility  of a  ~120-kD  transported  polypeptide  present  in 
both soluble and insoluble compartments. 
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tion of [35S]methionine into dorsal root ganglia. Each lane represents a 3-mm distal segment from the sciatic nerve of 7-wk-old animals 
killed 7 d after injection.  (A) Wild type. (B) NF-Hcos 65. (C) NF-Hcos 61. Transport of neurofilament subunits quantified by phosphor- 
imaging at (D-F) 7 and (G-/) 14 d after labeling. Each value represents  the average of three animals. 
the two effects result from the same mechanism: increased 
abundance of NF-H (Figs. 2 B  and 3 B) decreases the rate 
of neurofilament  transport  (Figs. 8 and 9) without affect- 
ing the content of other structural components (e.g., tubu- 
lin; Fig. 3 A). With production of a  constant overall level 
of newly synthesized subunits  (the  sum  of NF-L, NF-M, 
and NF-H) in perikarya, a small increase in the proportion 
of NF-H (Fig. 3, for lines 62 and 65) slows transport (Fig. 8) 
and  yields  increased  neurofilaments  in  proximal  axons 
(Fig.  3  B),  thereby  producing larger axons with  no peri- 
karyal abnormalities.  However, if transport is slowed fur- 
ther,  production  of  neurofilaments  exceeds  the  rate  at 
which  they  enter  axons,  causing  neurofilamentous  accu- 
mulations in the cell bodies. A  secondary consequence of 
retention of neurofilaments in the cell body is reduction of 
neurofilament  content  in  axons  (Fig.  3  B)  and  a  conse- 
quent inhibition of radial growth of large myelinated axons. 
Concerning the  mechanism of neurofilament-mediated 
radial growth, in combination with earlier transgenic mice 
expressing elevated levels of murine NF-L (Monteiro et al., 
1990; Xu et al., 1993) and epitope-tagged NF-M (Wong et al., 
1995a), it is now clear that significant increases in any sin- 
gle neurofilament subunit inhibit growth in caliber. On the 
other hand, modest increases in both NF-L and either NF-M 
or NF-H significantly promote  radial  growth  (Xu  et  al., 
1996).  As proposed earlier  (Xu et al.,  1996), the simplest 
view is that radial growth requires all three subunits: NF-L 
to support filament assembly, and a  scaffolding of NF-M 
Figure 10.  Pathologic consequences of continuous overexpression of wild-type murine NF-H in 2-yr-old animals. (A) Ventral horn motor 
neurons and skeletal muscle. (B) Proximal axonal swellings in ventral horn of spinal  cord in a 2-yr-old NF-Hcos 75 mouse. (Arrow) 
Proximal axonal swelling. (Arrowheads) Unmyelinated initial axonal segment. (C) Total number of axons in the IA and L5 ventral roots 
of 2-yr-old wild-type NF-Heos 75 mice. (n =  3 for wild-type;  n  =  2 for NF-Hcos 75.) Bars: (A) 100 txm (top), 20 I~m (middle), 100 g,m 
(bottom); (B) 50 I~m. 
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other axonal components. What is clear, however, is that 
changing the content of NF-H (with a corresponding re- 
duction in NF-M) does not affect nearest neighbor spacing 
of neurofilaments, a finding that goes hand in hand with 
the identical situation after doubling axonal NF-M and a 
corresponding loss in NF-H (Wong et al., 1995a). Since ra- 
dial growth can be markedly inhibited despite no change 
in  interfilament  distance,  this  finding  gives  additional 
weight to the argument that interactions between nearest 
neighbor filaments do not specify radial growth. The key 
property(ies) needed to stimulate caliber growth must in- 
clude longer range  interactions between neurofilaments 
that are not nearest neighbors or between neurofilaments 
and other axonal components. Attractive candidates for 
these additional interactions include the family of proteins 
such as BPAGln, proven recently to crossbridge between 
neurofilaments  and  actin  filaments  in  sensory  neurons 
(Yang et al., 1996). 
One probable mechanism through which elevated synthe- 
sis of NF-H retards neurofilament transport is by shifting 
an equilibrium toward  assembly of stationary neurofila- 
ments.  Two  pools  of neurofilaments  (and/or  neurofila- 
ment subunits) are known in axons, one moving at the tra- 
ditionally measured  slow  axonal  transport  rate  and  the 
other essentially stationary (Nixon and Logvinenko, 1986; 
Lasek et al.,  1992), although there is disagreement over 
the magnitude of the stationary phase. Assuming that sub- 
units reversibly cycle from the stationary phase back to the 
moving phase, an obvious possibility would be that NF-H 
tail-dependent crossbridging between filaments and/or to 
other axonal components yields a shift to the immobile (or 
less mobile) phase in the axons. In the cell bodies, similar 
cross-linking may block access of oligomers and/or poly- 
mers  as initial substrates  for entering the transport ma- 
chinery, hence resulting in perikarya swollen with assem- 
bled neurofilaments. 
Lastly, the absence of disease, motor neuron death, or 
denervation atrophy of skeletal muscle even in aged ani- 
mals expressing wild-type mouse NF-H at up to 4.5 times 
its normal rate offers strong evidence for the view that mo- 
tor neurons  are  remarkably tolerant  of misaccumulated 
neurofilaments assembled from wild-type subunits. No sig- 
nificant death of motor neurons is found in aged animals 
despite perikarya chronically distended with large masses 
of filaments, massive proximal axonal swellings (Fig. 10 B), 
and distal axonal atrophy (Figs. 5 D  and 10 A). This con- 
trasts  sharply with  the  situation  arising from expressing 
two to three times lower levels of human NF-H (Cote et al., 
1993). The human NF-H subunit, which differs from mouse 
NF-H in >160 amino acid positions scattered throughout 
the polypeptide backbone (counting the many sequence 
differences in the long KSP repeat domain as only a single 
difference; Julien et al., 1988; Lees et al.,  1988), results in 
progressive neuronopathy (Cote et al., 1993), inhibition of 
radial growth, and increased frequency of axonal degener- 
ation (Collard et al., 1995), albeit without significant de- 
crease in axon number even in aged animals (e.g., see total 
wild-type and transgenic axon number in Fig. 1 b of Col- 
lard et al., 1995). 
Disease developed by animals accumulating human NF-H 
led to the initial proposal that modest upregulation of NF-H 
cross-linkers impairs neurofilament transport, causing neuro- 
nal swellings with ensuing axonopathy and muscle atrophy 
(Cote et al., 1993; Collard et al., 1995).  However, the ab- 
sence of disease in any mice expressing varying amounts of 
mouse NF-H shows that the wild-type NF-H cannot pro- 
voke  similar  disease,  despite  slowing  of neurofilament 
transport to a comparable extent. The combined data in- 
stead strongly support the view that human NF-H causes 
disease in mice by acting as an aberrant, mutant subunit. A 
similar  situation  has  already  emerged  from  analysis  of 
mice  expressing  wild-type or mutant  NF-L subunits.  A 
doubling of murine NF-L content (and a corresponding in- 
crease in axonal neurofilaments) does not result in disease 
(Monteiro et al., 1990; Xu et al., 1993), whereas accumula- 
tion of one fourth as much of a point mutant in NF-L re- 
produces most features of ALS, including selective death 
of motor neurons (Lee et al.,  1994).  Wild-type NF-L pro- 
duces disease only when expressed at a  level that yields 
four times the normal number of axonal neurofilaments 
(Xu et al., 1993), ten times more than required to produce 
disease from accumulation of the mutant NF-L subunit, 
and even at this level, the wild-type protein does not cause 
motor neuron death. That neurons are remarkably toler- 
ant of wild-type neurofilaments is also consistent with the 
massive  intraaxonal accumulation of NFs resulting from 
selective detachment of neurofilaments from slow trans- 
port after administration of the drug 13,13'-iminodipropri- 
onitrile (IDPN). The giant axonal swellings do not yield 
neuronal death and disappear when IDPN is withdrawn 
(Clark et al., 1980). 
The combined findings offer strong support for the view 
that neurofilament-dependent dysfunction, degeneration, 
and/or  death  of  motor  neurons  in  mice  are  mediated 
through disorganized arrays of filaments impeding axonal 
transport, not only of neurofilaments (as seen in the mice 
expressing  wild-type  mouse  NF-H  presented  here)  but 
also of other components in both anterograde and/or ret- 
rograde movement (as seen in mice expressing human NF-H; 
Collard et al.,  1995).  Further evidence that disorganized 
neurofilament arrays can be toxic to neurons has emerged 
from analysis of the  absence of the neuronal isoform of 
BPAG1  (referred to as BPAGln  [Yang et al.,  1996]  or 
dystonin  [Brown  et  al.,  1995]),  a  protein  normally  ex- 
pressed exclusively in sensory neurons and that cross-links 
actin filaments and neurofilaments (Yang et al., 1996).  In 
the absence of BPAGln-dependent cross-linking, axonal 
architecture is markedly perturbed (Yang et al., 1996), and 
there  is  widespread  degeneration  and  death  of sensory 
neurons (Brown et al., 1995; Guo et al., 1995). 
Relative to the pathogenesis of disease, damage to and 
disorganization of filaments could arise either from direct 
mutation in neurofilaments (as proven in mice; Lee et al., 
1994),  from any number  of posttranslational  events,  or 
from  mutation  in  neurofilament-associated  components 
(e.g., BPAGln; Yang et al., 1996). Consistent with the first 
of these findings, in sporadic human ALS, two deletions in 
the KSP repeat domain of NF-H have been identified in 
five of 356 patients (Figlewicz et al.,  1994).  It must be ad- 
mitted, however, that examination of the KSP repeat do- 
main of NF-H (Rooke et al., 1996) or the entirety of the 
coding domains of NF-L, NF-M, or NF-H (Vechio et al., 
1996) have failed to uncover mutations linked to disease in 
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unlikely that neurofilament  mutations can account for a 
significant proportion  (if any) of inherited ALS.  On the 
other hand, in the 20%  of familial  ALS caused by muta- 
tion in the enzyme superoxide dismutase  1 (Rosen et al., 
1993), disease  (at least in mice)  arises from a toxic prop- 
erty of the mutant subunit (Wong et al., 1995b). Although 
the relevant  toxic property(ies)  is not yet identified, two 
plausible proposals are mutant enzyme-mediated nitration 
of protein-bound tyrosines (Beckman  et al., 1993) or ac- 
tion of the mutants as peroxidases  (Wiedau-Pazos  et al., 
1996).  Neurofilaments,  as  abundant  and  long-lived  pro- 
teins, are attractive candidates for progressively accumu- 
lating such chemical damage. Indeed, neurofilament accu- 
mulations are hallmarks of sporadic (Hirano et al., 1984a) 
and familial (Hirano et al., 1984b) disease, and they are es- 
pecially  conspicuous  in  disease  mediated  by  superoxide 
dismutase mutations (e.g., for mutations A4V [Hirano et al., 
1984a];  Shibata  et  al.,  1996;  and  Il13T  [Rouleau  et  al., 
1996]).  In  conjunction  with  the  earlier  evidence  from 
Julien  and  colleagues  (Cote  et  al.,  1993;  Collard  et  al., 
1995), the sum of the evidence thus strongly supports the 
view  that  aberrant  accumulations  of  axonal  neurofila- 
ments, whether primary or seconday insults, mediate neu- 
ronal failure through strangulation of the axonal transport 
that is so crucial to these large asymmetric cells. 
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